Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

NAFLD recurrence in liver transplant recipients.

Dureja P, Mellinger J, Agni R, Chang F, Avey G, Lucey M, Said A.

Transplantation. 2011 Mar 27;91(6):684-9. doi: 10.1097/TP.0b013e31820b6b84.

PMID:
21248661
2.

Recurrent disease following liver transplantation for nonalcoholic steatohepatitis cirrhosis.

Malik SM, Devera ME, Fontes P, Shaikh O, Sasatomi E, Ahmad J.

Liver Transpl. 2009 Dec;15(12):1843-51. doi: 10.1002/lt.21943.

3.

Non-alcoholic fatty liver disease after liver transplantation: a case of nurture and nature.

Ong J, Younossi ZM.

Am J Gastroenterol. 2010 Mar;105(3):621-3. doi: 10.1038/ajg.2009.720.

PMID:
20203643
4.

The impact of nonalcoholic fatty liver disease and the metabolic syndrome on progression of fibrosis in patients with recurrent HCV after liver transplantation.

Mindikoglu AL, Regev A, Casanova-Romero PY, Bejarano PA, Martinez EJ, Tzakis AG, Schiff ER.

Transplant Proc. 2006 Jun;38(5):1440-4.

PMID:
16797327
5.

Liver transplantation in nonalcoholic steatohepatitis is associated with high mortality and post-transplant complications: a single-center experience.

Heuer M, Kaiser GM, Kahraman A, Banysch M, Saner FH, Mathé Z, Gerken G, Paul A, Canbay A, Treckmann JW.

Digestion. 2012;86(2):107-13. doi: 10.1159/000339344.

PMID:
22846254
6.

Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients.

Ong JP, Elariny H, Collantes R, Younoszai A, Chandhoke V, Reines HD, Goodman Z, Younossi ZM.

Obes Surg. 2005 Mar;15(3):310-5.

PMID:
15826462
7.

De novo nonalcoholic fatty liver disease after liver transplantation.

Seo S, Maganti K, Khehra M, Ramsamooj R, Tsodikov A, Bowlus C, McVicar J, Zern M, Torok N.

Liver Transpl. 2007 Jun;13(6):844-7.

8.

Outcomes of liver transplantation in patients with cirrhosis due to nonalcoholic steatohepatitis versus patients with cirrhosis due to alcoholic liver disease.

Bhagat V, Mindikoglu AL, Nudo CG, Schiff ER, Tzakis A, Regev A.

Liver Transpl. 2009 Dec;15(12):1814-20. doi: 10.1002/lt.21927.

9.

Recurrence of non-alcoholic steatohepatitis and cryptogenic cirrhosis following orthotopic liver transplantation in the context of the metabolic syndrome.

El Atrache MM, Abouljoud MS, Divine G, Yoshida A, Kim DY, Kazimi MM, Moonka D, Huang MA, Brown K.

Clin Transplant. 2012 Sep-Oct;26(5):E505-12. doi: 10.1111/ctr.12014.

PMID:
23061759
10.

Nonalcoholic fatty liver disease: a manifestation of the metabolic syndrome.

Kim CH, Younossi ZM.

Cleve Clin J Med. 2008 Oct;75(10):721-8. Review.

PMID:
18939388
11.

Prevalence and clinical associations of posttransplant fatty liver disease.

Lim LG, Cheng CL, Wee A, Lim SG, Lee YM, Sutedja DS, Da Costa M, Prabhakaran K, Wai CT.

Liver Int. 2007 Feb;27(1):76-80.

PMID:
17241384
12.

Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis.

Contos MJ, Cales W, Sterling RK, Luketic VA, Shiffman ML, Mills AS, Fisher RA, Ham J, Sanyal AJ.

Liver Transpl. 2001 Apr;7(4):363-73.

PMID:
11303298
13.

Recurrent non-alcoholic steatohepatitis in a living related liver transplant recipient.

Saab S, Cho D, Lassman RC, Gajjar NA, Ghobrial M, Busuttil RW.

J Hepatol. 2005 Jan;42(1):148-9. No abstract available.

PMID:
15629523
14.

Nonalcoholic fatty liver disease after liver transplantation for cryptogenic cirrhosis or nonalcoholic fatty liver disease.

Yalamanchili K, Saadeh S, Klintmalm GB, Jennings LW, Davis GL.

Liver Transpl. 2010 Apr;16(4):431-9. doi: 10.1002/lt.22004.

15.

Evolution of nonalcoholic fatty liver disease recurrence after liver transplantation.

Patil DT, Yerian LM.

Liver Transpl. 2012 Oct;18(10):1147-53. doi: 10.1002/lt.23499. Review.

16.

Liver transplantation for primary biliary cirrhosis: results of aggressive corticosteroid withdrawal.

Campsen J, Zimmerman M, Trotter J, Wachs M, Bak T, Steinberg T, Kaplan M, Kam I.

Transplant Proc. 2009 Jun;41(5):1707-12. doi: 10.1016/j.transproceed.2008.10.095.

PMID:
19545712
17.

Metabolic syndrome and liver transplantation.

Hanouneh IA, Zein NN.

Minerva Gastroenterol Dietol. 2010 Sep;56(3):297-304.

PMID:
21037547
18.

Rapid recurrence of nonalcoholic fatty liver disease after transplantation in a child with hypopituitarism and hepatopulmonary syndrome.

Jonas MM, Krawczuk LE, Kim HB, Lillehei C, Perez-Atayde A.

Liver Transpl. 2005 Jan;11(1):108-10.

19.

Non-alcoholic fatty liver disease in liver transplant recipients: another story of "seed and soil".

Dumortier J, Giostra E, Belbouab S, Morard I, Guillaud O, Spahr L, Boillot O, Rubbia-Brandt L, Scoazec JY, Hadengue A.

Am J Gastroenterol. 2010 Mar;105(3):613-20. doi: 10.1038/ajg.2009.717.

PMID:
20040915
20.

The epidemiology of nonalcoholic fatty liver disease in adults.

Clark JM.

J Clin Gastroenterol. 2006 Mar;40 Suppl 1:S5-10. Review.

PMID:
16540768

Supplemental Content

Support Center